SAN DIEGO, Dec. 6, 2011 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc., a privately held biopharmaceutical company focused on the development of cancer therapeutics, announced the appointment of Kenneth Galbraith as Chairman of the Board.
SAN DIEGO, Dec. 6, 2011 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc., a privately held biopharmaceutical company focused on the development of cancer therapeutics, announced the appointment of Kenneth Galbraith as Chairman of the Board.
